How does clinical trial efficacy work (simply put)?

Post date: 2020-12-02 13:05:54
Views: 162
Confused about the data provided on the recent COVID studies, and why they mean vaccines were judged to be 95% effective

The Pfizer and Moderna press releases (Pfizer's linked here) provide three main pieces of data: the number of trial participants, the number of participants who contracted the virus, and the number of participants contracting the virus who were in the control group, receiving a placebo. (Apologies for any mistakes in terminology or anything else I'll be making here.)

So for Pfizer's trial, there were more than 43,000 participants, 170 of them contracting COVID, and 8 of them were in the vaccine group, meaning 162 were in the placebo group. 8/162 is ~5%.

The press releases don't say that this is why the vaccines are judged to be 95% effective, though papers like the Washington Post connect the dots. But how is this not the wrong way to judge effectiveness? Wouldn't the right way be to say 162 out of 16,200, e.g., taking the placebo contracted it, and that's 1%, and 8 of let's say 16,200 receiving the vaccine contracted it, and that's 5% of 1%, meaning the vaccine is 95% effective?
Number of Comments
Please click Here to read the full story.
 
Other Top and Latest Questions:
Here's why Jim Cramer thinks JPMorgan could be the next non-tech stock to reach a $1 trillion valuation
Longtime value investor Bill Nygren finds cheap stocks outside the 'Mag 7'
Wednesday's big stock stories: What’s likely to move the market in the next trading session
China's Baidu soars 16% to hit 2-year highs amid positive signs for its AI business
Microsoft, Nvidia, other tech giants plan over $40 billion of new AI investments in UK
China keeps tight grip on rare earths, costing at least one company 'millions of euros'
From royal pomp to Epstein embarrassment: Trump's UK state visit in pictures
StubHub to price IPO at $23.50, valuing company at $8.6 billion
Three things Britain wants from Trump's state visit — aside from business deals
Oracle and Silver Lake part of TikTok investor group as Trump extends deal deadline